Thermo Fisher Scientific will be at CPHI Barcelona, October 24-26. Find us at booth #3K50 or schedule a meeting today.
Characterizing viral vector products and associated impurities is critical to ensuring the safety and efficacy of viral vector therapies. View the following infographic for tips and aspects to consider for robust viral vector analytical characterization, including strategies to overcome challenges in assessing impurities and defining critical quality attributes (CQAs).